The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, cardiovascular, metabolism, and endocrinology disorders. The Electronics segment supplies materials comprising thin films, patterning and planarization formulations, specialty gases, optronics, and optical metrology equipment for the semiconductor and display industries. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector.
Cyborg Score Rationale
In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. The company maintains diversified revenue streams across healthcare, life sciences, and electronics, with recent strategic partnerships in drug development addressing significant unmet medical needs.
Top Insights
Merck KGaA agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially worth over $3 billion.
The company has in-licensing agreements with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer.
Merck KGaA is listed and trades on the Xetra stock exchange.
The company has 62,346 employees.
Named Competitors
Keytruda — Cancer immunotherapy drug
EMD Serono — Specialty pharmaceuticals in allergies, fertility, oncology
Roche Pharma — Oncology and diagnostics
Novartis Pharmaceuticals — Oncology and specialty care
Recent Developments
(February 2026) Valo Health collaboration for Parkinson's research valued at over $3 billion
(January 2026) JP Morgan and Kepler Capital maintained Buy ratings with price targets raised
(November 2025) Q3 2025 earnings call held
Open the full interactive Merck KGaA report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.